日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti-Programmed Death-Ligand 1 and Anti-Vascular Endothelial Growth Factor-A Antibodies.

血管内皮生长因子受体 2 靶向治疗可抑制甲胎蛋白阳性肝细胞癌在与抗程序性死亡配体 1 和抗血管内皮生长因子 A 抗体联合治疗后的进展。

Sugiyama Gen, Nio Kouki, Okada Hikari, Kida Akihiko, Sako Keisuke, Iwata Yasunori, Takayama Hideo, Kawakami Yutaro, Chiba Tomoyoshi, Nagai Kazuki, Sugimoto Saiho, Nishitani Masaki, Hayashi Tomoyuki, Takatori Hajime, Shimakami Tetsuro, Honda Masao, Yamashita Taro

Transcription factor JUNB is required for transformation of EpCAM-positive hepatocellular carcinoma (HCC) cells into CD90-positive HCC cells in vitro.

转录因子 JUNB 是 EpCAM 阳性肝细胞癌 (HCC) 细胞在体外转化为 CD90 阳性 HCC 细胞所必需的

Kawakami Yutaro, Okada Hikari, Nio Kouki, Hayashi Tomoyuki, Seki Akihiro, Nakagawa Hidetoshi, Yamada Shinya, Iida Noriho, Shimakami Tetsuro, Takatori Hajime, Honda Masao, Kaneko Shuichi, Yamashita Taro

Therapeutic effects of adipose tissue-derived mesenchymal stem cells on ER stress in a murine model of metabolic dysfunction-associated steatohepatitis: an in vivo and in vitro study.

脂肪组织来源间充质干细胞对代谢功能障碍相关脂肪性肝炎小鼠模型中内质网应激的治疗作用:一项体内和体外研究

Ogawa Norihiko, Seki Akihiro, Nasti Alessandro, Yagi Ho, Yamato Masatoshi, Inui Hiiro, Nomura Hiroki, Komura Takuya, Nakagawa Hidetoshi, Nio Kouki, Takatori Hajime, Shimakami Tetsuro, Honda Masao, Kaneko Shuichi, Sakai Yoshio, Yamashita Taro

Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice

临床实践中晚期肝细胞癌的综合基因组分析

Terashima, Takeshi; Yamashita, Tatsuya; Arai, Kuniaki; Takata, Noboru; Hayashi, Tomoyuki; Seki, Akihiro; Nakagawa, Hidetoshi; Nio, Kouki; Iida, Noriho; Yamada, Shinya; Shimakami, Tetsuro; Takatori, Hajime; Tsuji, Kunihiro; Sunagozaka, Hajime; Mizukoshi, Eishiro; Honda, Masao; Takeuchi, Shinji; Yamashita, Taro

Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib

阿特珠单抗联合贝伐珠单抗治疗既往接受过乐伐替尼治疗的晚期肝细胞癌患者的II期研究

Terashima, Takeshi; Kido, Hidenori; Takata, Noboru; Hayashi, Tomoyuki; Seki, Akihiro; Nakagawa, Hidetoshi; Nio, Kouki; Toyama, Tadashi; Iida, Noriho; Yamada, Shinya; Shimakami, Tetsuro; Takatori, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Mizukoshi, Eishiro; Yamashita, Taro

Metachronous Pancreatic Cancer with Pancreaticobiliary Maljunction Diagnosed Five Years after Cholecystectomy for Gallbladder Cancer, in Which Follow-up Imaging Was Possible Until the Onset of Cancer: A Case Report and Review of the Literature

一例胆囊癌患者在胆囊切除术后五年被诊断出患有异时性胰腺癌伴胰胆管汇合异常,且在癌症发生前均可进行影像学随访:病例报告及文献复习

Miyazawa, Masaki; Yanagi, Masahiro; Chiba, Tomoyoshi; Nagai, Kazuki; Kido, Hidenori; Sugimoto, Saiho; Nishitani, Masaki; Orita, Noriaki; Takata, Noboru; Hayashi, Tomoyuki; Seki, Akihiro; Nakagawa, Hidetoshi; Nio, Kouki; Terashima, Takeshi; Iida, Noriho; Yamada, Shinya; Takatori, Hajime; Shimakami, Tetsuro; Mizukoshi, Eishiro; Honda, Masao; Yamashita, Taro

Utility of oral rehydration jelly in probe method endoscopic ultrasound: a prospective cohort study

口服补液盐在探针式内镜超声中的应用:一项前瞻性队列研究

Yamada, Shinya; Takatori, Hajime; Miyazawa, Masaki; Hayashi, Tomoyuki; Seki, Akihiro; Nakagawa, Hidetoshi; Nio, Kouki; Iida, Noriho; Shimakami, Tetsuro; Yamashita, Taro

Unveiling the Impact of BMP9 in Liver Diseases: Insights into Pathogenesis and Therapeutic Potential

揭示BMP9在肝脏疾病中的作用:对发病机制和治疗潜力的深入理解

Chen, Han; Li, Ying-Yi; Nio, Kouki; Tang, Hong

Photodynamic therapy with talaporfin sodium for endoscopically unresectable gastric cancer using a novel simultaneous light-emitting method

采用新型同步发光方法,利用他拉泊芬钠进行光动力疗法治疗内镜下无法切除的胃癌

Hayashi, Tomoyuki; Hayashi, Kotaro; Terashima, Takeshi; Nishitani, Masaki; Orita, Noriaki; Miyazawa, Masaki; Seki, Akihiro; Nakagawa, Hidetoshi; Nio, Kouki; Iida, Noriho; Yamada, Shinya; Takatori, Hajime; Shimakami, Tetsuro; Yamashita, Taro

Higher FIB-4 index at baseline predicts development of liver cancer in a community-based cohort with viral hepatitis

基线时较高的FIB-4指数可预测社区病毒性肝炎患者发生肝癌的风险。

Kimura, Makiko; Nishikawa, Tomoki; Shimakami, Tetsuro; Terashima, Takeshi; Horii, Rika; Fukuda, Masako; Yoshita, Mika; Takata, Noboru; Hayashi, Tomoyuki; Funaki, Masaya; Nio, Kouki; Takatori, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Honda, Masao; Tanaka, Junko; Kaneko, Shuichi; Yamashita, Taro